Page 14 - Phase 3 News Today

Trials of homegrown COVID-19 vaccine show positive signs Chia sẻ | FaceBookTwitter Email Copy Link Copy link bài viết thành công  05/06/2021    14:28 GMT+7 The clinical trials of Vietnamese COVID-19 vaccine candidate Nano Covax are set to enter Phase 3 this month with the optimal dosage of 25mcg, aiming to further test the safety and efficacy of the vaccine in humans before mass pr...

The clinical trials of Vietnamese COVID-19 vaccine candidate Nano Covax are set to enter Phase 3 this month with the optimal dosage of 25mcg, aiming to further test the safety and efficacy of the vaccine in humans before mass production begins.

The EMPHATHY clinical trial will enroll patients with COVID-19 to test the drug’s effectiveness in preventing worsening of symptoms and hospitalization. Novartis and Molecular Partners have announced the start of their EMPATHY Phase II/III study to explore the use of its DARPin (designed ankyrin repeat proteins) therapeutic candidate ensovibep (MP0420) for the treatment of COVID-19. Novartis reportedly will run the trial program, with Molecular Partners serving as ...

New Delhi [India], May 28 (ANI): India achieved a significant landmark in its ongoing COVID-19 vaccination drive as the cumulative number of coronavirus vaccines administered cross 21 crores on Saturday, according to the Union Ministry of Health and Family Welfare (MoHFW).

New Delhi [India], May 28 (ANI): India achieved a significant landmark in its ongoing COVID-19 vaccination drive as the cumulative number of coronavirus vaccines administered reached the 20.86 crore mark on Friday, according to the Union Ministry of Health and Family Welfare (MoHFW).

The Latest: UK says variant could delay ending restrictions The Associated Press FacebookTwitterEmail 14 1of14Traffic is controlled at a COVID-19 testing facility in Melbourne, Australia, Thursday, May 27, 2021, Australia’s second largest city announced a seven-day lockdown on Thursday as concern grows over dozens of cases of a COVID-19 variant found in India. (James Ross/AAP Image via AP)James Ross/APShow MoreShow Less 2of14A customer wearing a protective mask to help curb the sp...

PARIS (AP) — Production of another potential vaccine against COVID-19 will begin within...

Are only getting pfizer. how big of a deal will it be if moderna gets approved as well? >> now well have both moderna and pfizer vaccine for adolescents. they were both 100% protective. its a small sampling compared to the earlier phase 3 trial. so the 100% will probably not hold up but its still very, very high. high levels of protections and antibodies, at least for the pfizer vaccine, so its a good vaccine. what that means is if we can get a significant percentage of both adults and adolescen...

WEST LAFAYETTE, Ind., May 20, 2021 /PRNewswire/ -- On Target Laboratories, Inc., a privately held biotechnology company developing fluorescent markers to target and illuminate cancer during surgery, today announced results of the 006 Study, a Phase 3, randomized, multi-center, prospective, open-label study to investigate the safety and efficacy of pafolacianine sodium injection (OTL38) for intraoperative imaging of folate receptor positive ovarian cancer. In 33% of patients (36 of 109), near-in...

Optimus Pharma gets nod for phase 3 trials of Molnupiravir capsule Updated: Updated: Share Article AAA Drug-maker Optimus Pharma on Wednesday said it received approval of the Drugs Controller General of India (DCGI) to conduct Phase III clinical trials for Molnupiravir capsule on mild and moderate COVID-19 patients. As per the clinical trial protocols approved, a total of 2,500 subjects in both mild and moderate COVID-19 will be randomised in the study in a 1:1 ratio to Molnupiravir with stan...